Description: What Went Wrong: The Truth Behind the Clinical Trial of the Enzyme Treatment of Cancer Nicholas J. Gonzalez MD and Linda L. Isaacs MD Product Overview In 1998, Nicholas Gonzalez, M.D. received National Cancer Institute approval for a clinical trial to evaluate his nutritional-enzyme approach in the treatment of patients with pancreatic cancer. Though Dr. Gonzalez hoped the venture would initiate cooperation between conventional scientists and serious alternative researchers, problems plagued the study from its inception. The design discouraged patient participation; oncologists discouraged patients from joining and at times pressured those already admitted for nutritional therapy to change to conventional treatment. Then in 2000 the NCI turned over all patient selection decisions to the Principal Investigator (PI), who as it turned out helped devise the chemotherapy regimen used as the control treatment. Repeatedly, the PI approved patients for the nutritional treatment who did not meet the entry requirements, or who were too ill or uncommitted to follow the self-administered regimen. An evaluation by government scientists in early 2005 confirmed that so many patients had failed to follow the prescribed nutritional therapy that the data had little meaning. Despite such problems, without Dr. Gonzalez' knowledge the Principal Investigator published an article implying the study was properly run, patients complied fully and that the nutritional therapy had no effect. In response, Dr. Gonzalez, a former journalist, has written What Went Wrong, to bring the truth of this project to light, and show how bias, indifference, and at times incompetence undermined a promising research effort that, if properly run, might have ushered in a new direction in cancer treatment. Dr. Gonzalez graduated from Brown University (Phi Beta Kappa, magna cum laude). He worked as a journalist at Time Inc. before pursuing premedical studies at Columbia and medical school at Cornell. Dr. Gonzalez completed immunology training before opening a practice in New York in 1987. His research has been funded by Procter & Gamble and Nestle. Read more Details Publisher : New Spring Press (July 1, 2012) Language : English Hardcover : 616 pages ISBN-10 : 0982196539 ISBN-13 : 33 Item Weight : 2.6 pounds Best Sellers Rank: #1,300,326 in Books (See Top 100 in Books) Customer Reviews: 4.8 4.8 out of 5 stars 25 ratings Quality Products This will be shipped securely Returns must be within 30 days - item EXACTLY as it was sent. Must have tracking number. Email us with any issues/questions. Thanks for looking! Fast and Free Shipping Shipping is free for this item. We get your order shipped out and delivered to your doorstep as quickly as possible. Commitment We are committed to making sure that you leave this transaction satisfied. That means having access to real people that get your questions and concerns answered quickly. Give us a shot and we will make sure that you will look to us again!
Price: 42.86 USD
Location: US
End Time: 2024-11-20T17:28:14.000Z
Shipping Cost: 0 USD
Product Images
Item Specifics
Return shipping will be paid by: Seller
All returns accepted: Returns Accepted
Item must be returned within: 30 Days
Refund will be given as: Money Back
Return policy details:
ISBN: 0982196539
ISBN10: 0982196539
ISBN13: 9780982196533
EAN: 9780982196533
MPN: does not apply
Brand: NA
Number of Pages: Xxviii, 583 Pages
Publication Name: What Went Wrong : the Truth Behind the Clinical Trial of the Enzyme Treatment of Cancer
Language: English
Publisher: New Spring Press, LLC
Publication Year: 2012
Subject: Clinical Medicine, Oncology
Item Weight: 44.1 Oz
Type: Textbook
Item Length: 10 in
Author: Nicholas J. Gonzalez
Subject Area: Medical
Item Width: 7 in
Format: Hardcover